| Psychological therapies for the treatment of mental disorders in low‐and middle‐income countries affected by humanitarian crises M Purgato, C Gastaldon, D Papola, M Van Ommeren, C Barbui, WA Tol Cochrane database of systematic reviews, 2018 | 232 | 2018 |
| Efficacy of psychosocial interventions for mental health outcomes in low-income and middle-income countries: an umbrella review C Barbui, M Purgato, J Abdulmalik, C Acarturk, J Eaton, C Gastaldon, ... The Lancet Psychiatry 7 (2), 162-172, 2020 | 199 | 2020 |
| Focused psychosocial interventions for children in low-resource humanitarian settings: a systematic review and individual participant data meta-analysis M Purgato, AL Gross, T Betancourt, P Bolton, C Bonetto, C Gastaldon, ... The Lancet Global Health 6 (4), e390-e400, 2018 | 150 | 2018 |
| Fluoxetine versus other types of pharmacotherapy for depression LR Magni, M Purgato, C Gastaldon, D Papola, TA Furukawa, A Cipriani, ... Cochrane Database of Systematic Reviews, 2013 | 124 | 2013 |
| Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations G Ostuzzi, D Papola, C Gastaldon, G Schoretsanitis, F Bertolini, ... Focus 18 (4), 466-481, 2020 | 115 | 2020 |
| Paroxetine versus other anti‐depressive agents for depression M Purgato, D Papola, C Gastaldon, C Trespidi, LR Magni, C Rizzo, ... Cochrane Database of Systematic Reviews, 2014 | 85 | 2014 |
| Post-marketing safety concerns with esketamine: a disproportionality analysis of spontaneous reports submitted to the FDA adverse event reporting system C Gastaldon, E Raschi, JM Kane, C Barbui, G Schoretsanitis Psychotherapy and Psychosomatics 90 (1), 41-48, 2020 | 81 | 2020 |
| Antipsychotic use and risk of life‐threatening medical events: umbrella review of observational studies D Papola, G Ostuzzi, C Gastaldon, GP Morgano, E Dragioti, AF Carvalho, ... Acta Psychiatrica Scandinavica 140 (3), 227-243, 2019 | 75 | 2019 |
| Maintenance treatment with long-acting injectable antipsychotics for people with nonaffective psychoses: a network meta-analysis G Ostuzzi, F Bertolini, C Del Giovane, F Tedeschi, C Bovo, C Gastaldon, ... American Journal of Psychiatry 178 (5), 424-436, 2021 | 65 | 2021 |
| Effectiveness of self-help plus in preventing mental disorders in refugees and asylum seekers in Western Europe: a multinational randomized controlled trial M Purgato, K Carswell, F Tedeschi, C Acarturk, M Anttila, T Au, M Bajbouj, ... Psychotherapy and psychosomatics 90 (6), 403-414, 2021 | 63 | 2021 |
| Psychological and social interventions for the prevention of mental disorders in people living in low‐and middle‐income countries affected by humanitarian crises D Papola, M Purgato, C Gastaldon, C Bovo, M van Ommeren, C Barbui, ... Cochrane Database of Systematic Reviews, 2020 | 54 | 2020 |
| Oral and long‐acting antipsychotics for relapse prevention in schizophrenia‐spectrum disorders: a network meta‐analysis of 92 randomized trials including 22,645 participants G Ostuzzi, F Bertolini, F Tedeschi, G Vita, P Brambilla, L Del Fabro, ... World Psychiatry 21 (2), 295-307, 2022 | 53 | 2022 |
| Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches G Ostuzzi, C Gastaldon, D Papola, A Fagiolini, S Dursun, D Taylor, ... Therapeutic Advances in Psychopharmacology 10, 2045125320942703, 2020 | 50 | 2020 |
| Factors associated with first-versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy G Ostuzzi, MA Mazzi, S Terlizzi, F Bertolini, A Aguglia, F Bartoli, ... PloS one 13 (8), e0201371, 2018 | 50 | 2018 |
| Risk factors of postpartum depression and depressive symptoms: umbrella review of current evidence from systematic reviews and meta-analyses of observational studies C Gastaldon, M Solmi, CU Correll, C Barbui, G Schoretsanitis The British Journal of Psychiatry 221 (4), 591-602, 2022 | 48 | 2022 |
| Esketamine for treatment resistant depression: a trick of smoke and mirrors? C Gastaldon, D Papola, G Ostuzzi, C Barbui Epidemiology and Psychiatric Sciences 29, e79, 2020 | 45 | 2020 |
| Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta … G Ostuzzi, G Vita, F Bertolini, F Tedeschi, B De Luca, C Gastaldon, ... The Lancet Psychiatry 9 (8), 614-624, 2022 | 40 | 2022 |
| Comparative efficacy and acceptability of psychotherapies for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled … D Papola, G Ostuzzi, F Tedeschi, C Gastaldon, M Purgato, C Del Giovane, ... The British Journal of Psychiatry 221 (3), 507-519, 2022 | 32 | 2022 |
| A systematic review and pooled, patient‐level analysis of predictors of mortality in neuroleptic malignant syndrome D Guinart, F Misawa, JM Rubio, J Pereira, R de Filippis, C Gastaldon, ... Acta Psychiatrica Scandinavica 144 (4), 329-341, 2021 | 32 | 2021 |
| Benzodiazepines and risk of dementia: true association or reverse causation? C Barbui, C Gastaldon, A Cipriani Epidemiology and psychiatric sciences 22 (4), 307-308, 2013 | 30 | 2013 |
Corrado BarbuiProfessor of Psychiatry, WHO Collaborating Centre, University of Verona, ItalyVerified email at univr.it
